Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study
Latest Information Update: 26 Dec 2018
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms X-PRESS
- Sponsors Bayer
- 18 Apr 2018 Status changed from active, no longer recruiting to completed.
- 11 Oct 2017 Planned primary completion date changed from 31 Dec 2017 to 30 Jan 2018.
- 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.